IOVANCE BIOTHERAPEUTICS, INC.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2023 | 13.1% | -38,735.0% | -37,345.4% |
| FY2024 | 43.2% | -240.9% | -226.8% |
| FY2025 | 34.3% | -153.1% | -148.4% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2023 | 13.1% | -38,735.0% | -37,345.4% |
| FY2024 | 43.2% | -240.9% | -226.8% |
| FY2025 | 34.3% | -153.1% | -148.4% |